Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
SLNO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SLNO - Soleno Therapeutics, Inc.
180 M
LAST VALUE
3652.86%
2 YEAR CAGR
58.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR